Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors.

ABSTRACT:

SUBMITTER: Kongtim P 

PROVIDER: S-EPMC6192023 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature